Health Insurance - Coordination of Benefits - Carrier Responsibilities and Retroactive Denials of Reimbursement
Summary
HB1450 amends Maryland’s Small Business Innovation Research and Technology Transfer Incentive Program. The bill removes several statutory limits that previously capped the size and number of awards or investments a small business could receive under the program, while retaining the program’s core structure and administration by the Maryland Technology Development Corporation (TEDCO). It also preserves the requirement that the program prioritize businesses working on research and development that helps prevent, prepare for, or respond to public health crises in Maryland.
Under the bill, eligible small businesses may still receive matching awards or investments tied to federal SBIR and STTR awards, but the prior dollar caps and fiscal-year limits are repealed. The bill keeps the competitive quarterly application process and the factors TEDCO must consider, including the impact of the funding and how it will support commercialization. It also continues the program’s outreach and coordination requirements with state and county programs, including efforts to reach economically disadvantaged, minority-owned, women-owned, rural, and first-time applicants.
Impact
HB1450 changes Section 10-476 of the Economic Development Article by repealing statutory limits on award amounts and the number of awards/investments that could be made under the Maryland Small Business Innovation Research and Technology Transfer Incentive Program. As a result, TEDCO has greater discretion to size and structure awards for eligible small businesses, subject to available funding and program criteria. The bill does not alter the program’s basic eligibility framework, but it expands flexibility for supporting commercialization and public-health-related innovation among Maryland small businesses.
Sentiment
The bill appears to have been broadly supported in the legislature, as reflected by strong third-reading passage in both chambers. The available record shows no committee transcript opposition or recorded debate, and the bill was ultimately enacted. The overall sentiment suggests lawmakers viewed the change as a practical adjustment to improve the program’s usefulness and responsiveness to small business innovation needs.
Contention
The main policy issue in HB1450 is the repeal of explicit statutory caps on award size and frequency. Supporters likely favored giving TEDCO more flexibility to make larger or more tailored investments when warranted, especially for businesses with promising commercialization potential or public health applications. Any concern would center on reduced legislative control over how much public money can be awarded to a single business or in a given year, but the record provided does not show organized opposition or specific objections.